These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 13332559)

  • 1. Ganglionic blocking properties of 3-methylaminoisocamphane hydrochloride (mecamylamine): a secondary amine.
    STONE CA; TORCHIANA ML; NAVARRO A; BEYER KH
    J Pharmacol Exp Ther; 1956 Jun; 117(2):169-83. PubMed ID: 13332559
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal elimination of 3-methylaminoisocamphane hydrochloride (mecamylamine).
    BAER JE; BEYER KH; PAULSON SF; RUSSO HF
    Am J Physiol; 1956 Jul; 186(1):180-6. PubMed ID: 13354778
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug therapy of hypertension. II. Experience with reserpine, apresoline, ansolysen, ecolid, and mecamylamine (inversine).
    MOSER M; MACAULAY AI; GRANZEN R; TROUT KW
    N Y State J Med; 1956 Aug; 56(16):2487-97. PubMed ID: 13348892
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug therapy (mecamylamine) of hypertension. III. Results with mecamylamine, a completely absorbed ganglionic blocking agent.
    CAPLOVITZ C; CONNER PK; DENNIS E; FORD R; HERSHBERGER R; KINARD S; MCCONN R; MOYER JH
    AMA Arch Intern Med; 1956 Aug; 98(2):187-210. PubMed ID: 13354014
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastrointestinal secretion and absorption of 3-methylaminoisocamphane hydrochloride (mecamylamine).
    ZAWOISKI EJ; BAER JE; BRAUNSCHWEIG LW; PAULSON SF; SHERMER A; BEYER KH
    J Pharmacol Exp Ther; 1958 Apr; 122(4):442-8. PubMed ID: 13539770
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental & clinical observation on the activity of a new synthetic ganglioplegic: mecamylamine (3-methylaminoisocamphane hydrochloride)].
    MARCHETTI G; NAVA S; TARTARA A
    Minerva Med; 1958 Feb; 49(15):606-14. PubMed ID: 13541046
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mecamylamine; a new ganglion-blocking agent for management of hypertension].
    WERKO L
    Sven Lakartidn; 1956 Nov; 53(44):2880-3. PubMed ID: 13380780
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of the effect of certain ganglion-blocking agents by gamma-methyl amide of camphoric acid].
    HAVA M; KREJCI I; NECINA J
    Cesk Fysiol; 1960 May; 9():286-7. PubMed ID: 13712358
    [No Abstract]   [Full Text] [Related]  

  • 9. MECAMYLAMINE hydrochloride.
    J Am Med Assoc; 1956 Dec; 162(16):1469-71. PubMed ID: 13376320
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigation of the mechanism of the hemodynamic effects of ganglionic blockade produced by mecamylamine.
    ROWE GG; MAXWELL GM; CASTILLO CA; FREEMAN DJ; CRUMPTON CW
    Am Heart J; 1960 Nov; 60():777-84. PubMed ID: 13744130
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacology of mecamylamine.
    FORD RV; MADISON JC; MOYER JH
    Am J Med Sci; 1956 Aug; 232(2):129-43. PubMed ID: 13339785
    [No Abstract]   [Full Text] [Related]  

  • 12. Mecamylamine, a new, orally effective, hypotensive agent; experimental and clinical evaluation.
    FREIS ED; WILSON IM
    AMA Arch Intern Med; 1956 May; 97(5):551-61. PubMed ID: 13312697
    [No Abstract]   [Full Text] [Related]  

  • 13. The side effects of mecamylamine hydrochloride: a review of 50 cases.
    MUNSTER AM
    Med J Aust; 1961 Feb; 48(1)():247-9. PubMed ID: 13726855
    [No Abstract]   [Full Text] [Related]  

  • 14. Laboratory and clinical observations on mecamylamine as a hypotensive agent.
    MOYER JH; FORD R; DENNIS E; HANDLEY CA
    Proc Soc Exp Biol Med; 1955 Nov; 90(2):402-8. PubMed ID: 13273462
    [No Abstract]   [Full Text] [Related]  

  • 15. A series of tris (dialkylaminoalkyl) amines with ganglionic blocking activity.
    PLUMMER AJ; SCHNEIDER JA; BARRETT WE
    Arch Int Pharmacodyn Ther; 1954 Feb; 97(1):1-12. PubMed ID: 13159447
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of hypertension with pentapirrolidínea and mecamylamine].
    COSSIO P; ELIZALDE A
    Prensa Med Argent; 1956 Jun; 43(24):1889-94. PubMed ID: 13379184
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of 3-methylaminoisocamphane hydrochloride in tablets].
    REGHINI A; VIDALI P
    Farmaco Prat; 1957 Feb; 12(2):73-5. PubMed ID: 13427756
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of mecamylamine and pempidine, secondary and tertiary amines, on the spinal reflex of cats (author's transl)].
    Yamada S; Hachisu M; Ohata H; Kamimura T; Maruyama I
    Nihon Yakurigaku Zasshi; 1981 May; 77(5):469-76. PubMed ID: 7297958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiments with a new ganglion-blocking agent, mecamylamine hydrochloride in the treatment of arterial hypertension].
    MENDEZ L; FIGUEROA G
    Arch Inst Cardiol Mex; 1957; 27(4):399-410. PubMed ID: 13471314
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary amine/(+)-CSA salt-promoted organocatalytic conjugate addition of nitro esters to enones.
    Liu C; Lu Y
    Org Lett; 2010 May; 12(10):2278-81. PubMed ID: 20411973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.